Ensysce Biosciences, Inc.

General ticker "ENSC" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $5.7M (TTM average)

Ensysce Biosciences, Inc. does not follow the US Stock Market performance with the rate: -3.4%.

Estimated limits based on current volatility of 5.5%: low 1.52$, high 1.70$

Factors to consider:

  • Total employees count: 7 (0.0%) as of 2024
  • Top business risk factors: Going concern, Profitability concerns, Labor/talent shortage/retention, Manufacturing risks, Intellectual property risks
  • Current price 60.9% below estimated low
  • Earnings for 9 months up through Q3 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [4.17$, 15.97$]
  • 2025-12-31 to 2026-12-31 estimated range: [2.64$, 10.94$]

Financial Metrics affecting the ENSC estimates:

  • Negative: with PPE of -0.6 at the end of fiscal year the price was high
  • Negative: negative Operating income
  • Negative: Operating cash flow per share per price, % of -51.29 <= 0.33
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Net income
  • Positive: Investing cash flow per share per price, % of 0 > -0.66
  • Negative: Interest expense per share per price, % of 8.82 > 3.41
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term ENSC quotes

Long-term ENSC plot with estimates

Financial data

YTD 2023-12-31 2024-12-31
Operating Revenue $2.23MM $5.21MM
Operating Expenses $12.95MM $11.94MM
Operating Income $-10.72MM $-6.73MM
Non-Operating Income $-0.20MM $-1.26MM
Interest Expense $0.35MM $1.29MM
R&D Expense $7.59MM $7.22MM
Income(Loss) $-10.92MM $-7.99MM
Profit(Loss)* $-10.61MM $-7.99MM
Stockholders Equity $-0.32MM $3.71MM
Assets $2.71MM $5.60MM
Operating Cash Flow $-10.78MM $-7.50MM
Financing Cash Flow $8.76MM $9.88MM
Earnings Per Share** $-4.69 $-4.57

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.